Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The aims of this clinical trial will test whether or not the onset of nearsightedness is delayed in a group of children randomized to nightly drops in 0.05% atropine in both eyes, in comparison to children who receiving nightly placebo drops in both eyes. The primary outcome is the two-year cumulative incidence of nearsightedness. The second aim of this project will determine whether atropine is associated with slower eye growth in children receiving nightly drops of atropine versus placebo.
Epistemonikos ID: 2e677e34ef0584130c766fde15712cc855cfdd3c
First added on: May 05, 2026